Backed by research around the world in peer-reviewed journals, MERU VasImmune’s research-use-only antibodies are well-characterized and deliver superior analytical performance. Our antibodies are highly affordable to support a wide range of research aims and budgets.
5A7 is a single rat mAb against mouse GPIbα used to deplete platelets in mice.
P 3 is a sub-nanomolar affinity mAb for human GPIbα used to phenotype platelets and for immunoprecipitation experiments. Available both as IgG or Fab. Fluorescent versions of P3 (Catalog No. MVI-1003) can be used to visualize platelets in microscopy experiments.
The labelled version of P3 Fab can be used to track human platelets in whole blood microscopy experiments and for a correct and precise determination of the number of GPIbα molecules on platelet surface.
CP8 is a mAb directed against the human αIIbβ3 integrin that blocks both fibrinogen and VWF-mediated aggregation under shear stress.
134B29 is a mouse mAb that blocks RGD-specific function selectively in human fibrinogen.
152B6 is a mouse mAb that blocks RGD-specific function selectively in human VWF.
Directed against a neo-epitope present in human fibrin but not fibrinogen, 64C5 allows for the quantitative analysis of fibrin generation. It also reacts with mouse fibrin and is available dye-labeled for fluorescence-based applications.
P5 is a mAb directed against the human αIIbβ3 integrin, blocking only VWF-mediated aggregation under shear stress.
RG24 mAb targets the aminoacid sequence (948-1051) of human WVF. Used in Western Blot, in combination with RG34, it can discriminate between the proteolytic fragments generated by plasmin and ADAMTS13..
RG34 mAb targets the aminoacid sequence (2593-2813) of human WVF. Used in Western Blot, in combination with RG34, it can discriminate between the proteolytic fragments generated by plasmin and ADAMTS13.